Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Oncology · Hepatocellular Carcinoma

Child-Pugh vs. ALBI for HCC: What Do They Mean for You?

At a Glance

For people with hepatocellular carcinoma, the Child-Pugh score combines blood tests with ascites and confusion, while the ALBI grade uses albumin and bilirubin alone. Doctors use both, along with tumor extent and overall health, to guide treatment and estimate risk.

When you are diagnosed with hepatocellular carcinoma (HCC), your care team must evaluate not just your cancer, but also how well your liver is functioning. This is because many HCC treatments can be hard on the liver. To measure your liver reserve—how much healthy liver function you have left—doctors use various scoring systems. Two commonly used tools are the Child-Pugh score and the ALBI grade [1].

The traditional Child-Pugh score includes physical symptoms—like fluid buildup and confusion—alongside blood tests [2]. The newer ALBI grade relies purely on a mathematical formula using two objective blood tests: albumin and bilirubin [3][1]. Rather than replacing the Child-Pugh score, the ALBI grade is increasingly used alongside it to provide a more detailed, objective picture of your liver health [4][5].

The Child-Pugh Score: The Traditional Clinical Assessment

For decades, the Child-Pugh score has been a standard way to grade liver function in people with cirrhosis or liver cancer. It assigns points based on five factors [1]:

  • Bilirubin: A yellow pigment in the blood that shows how well the liver is clearing waste.
  • Albumin: A protein made by the liver.
  • Prothrombin Time (or INR): A marker of how well the liver is producing clotting factors, often called synthetic function.
  • Ascites: The amount of fluid built up in your abdomen.
  • Hepatic Encephalopathy: The degree of confusion or brain fog caused by a buildup of liver toxins.

Based on these factors, patients are grouped into Class A (well-functioning), Class B (moderate impairment), or Class C (severe impairment) [1].

While the Child-Pugh score is highly valuable because it assesses real-world physical symptoms, it has a limitation: subjectivity [6]. Estimating the exact severity of ascites or encephalopathy can vary between different doctors [2][6]. Furthermore, symptoms like confusion can temporarily change depending on infections or medications.

The ALBI Grade: An Objective Laboratory Tool

To provide an objective measure alongside clinical exams, researchers developed the ALBI grade, which stands for Albumin-Bilirubin [1].

The ALBI score is calculated using only two routine blood tests [3]:

  • Albumin
  • Bilirubin

Doctors plug these numbers into a specific formula: (0.66 × log10 bilirubin) + (−0.085 × albumin) [3]. The resulting score groups patients into three grades [1][3]:

  • Grade 1: Score of -2.60 or lower (strongest liver function)
  • Grade 2: Score between -2.60 and -1.39 (moderate impairment)
  • Grade 3: Score higher than -1.39 (severe impairment)

Note: You should not attempt to calculate or interpret this score on your own, as different laboratory testing methods and unit conversions can alter the math.

Because it only uses lab numbers, the ALBI grade reduces the subjectivity of human observation [7]. However, it is not perfect. Albumin and bilirubin can be influenced by other factors that have nothing to do with your liver’s reserve, such as kidney dysfunction, poor nutrition, inflammation, or a benign condition called Gilbert syndrome [2][8][9]. Because of this, an ALBI score must always be interpreted in the context of your overall health.

How Doctors Use Both Scores Together

Many oncologists and hepatologists now use the ALBI grade to complement the Child-Pugh score for several reasons:

  • Finding Subtle Differences: The ALBI grade is excellent at detecting subtle variations in liver health among patients who all seem relatively healthy under the Child-Pugh system. It can split patients who are all lumped together in “Child-Pugh Class A” into different risk groups [2][7][10].
  • Estimating Treatment Risk: ALBI may help estimate the risk of complications from rigorous treatments like surgery (liver resection), radiation, or targeted systemic therapies [11][12][10]. For instance, a higher ALBI grade can act as a warning signal that a patient may be at higher risk for liver failure after surgery, prompting the surgical team to do further testing [11].
  • Survival Prediction: In several large studies, the ALBI grade has shown it can be very useful for predicting long-term outcomes for HCC patients, sometimes offering better discrimination than the Child-Pugh score [13][14][10].

No single score makes a treatment decision.
The ALBI grade does not measure important physical issues like portal hypertension (high blood pressure in the liver’s veins) or ascites, which is why it cannot replace a doctor’s physical exam [4][5]. Your care team will look at your ALBI grade, your Child-Pugh score, your tumor burden, and your overall physical strength to determine the safest treatment plan for you.

Common questions in this guide

What is the difference between the Child-Pugh score and ALBI grade in HCC?
The Child-Pugh score combines bilirubin, albumin, clotting time, ascites, and hepatic encephalopathy. The ALBI grade uses only albumin and bilirubin in a formula, so it is more objective but does not capture physical findings such as ascites or confusion. Doctors often use the two together rather than treating ALBI as a replacement.
What do Child-Pugh Classes A, B, and C mean?
Child-Pugh Class A generally indicates the best-preserved liver function, Class B indicates moderate impairment, and Class C indicates severe impairment. The classification is based on bilirubin, albumin, clotting time, ascites, and hepatic encephalopathy. Your care team interprets the class alongside your cancer and overall health.
What do ALBI Grades 1, 2, and 3 mean?
ALBI Grade 1 indicates the strongest liver function, Grade 2 indicates moderate impairment, and Grade 3 indicates severe impairment. The grade is calculated from albumin and bilirubin values. A clinician should interpret the result because laboratory methods, units, and other health conditions can affect the calculation.
How can these liver function scores affect HCC treatment?
The scores help the care team estimate whether your liver may tolerate treatments such as surgery, radiation, or targeted systemic therapy. A higher ALBI grade may signal less liver reserve and a greater risk of complications, including liver failure after surgery. No score alone determines treatment; tumor burden, physical strength, and other health factors also matter.
Can kidney problems or nutrition change my ALBI result?
Yes. Kidney dysfunction, poor nutrition, inflammation, and Gilbert syndrome can affect albumin or bilirubin without accurately reflecting the liver reserve that the ALBI grade is intended to measure. Your doctor should interpret the result in the context of your complete medical history and other tests.
What important liver problems do the Child-Pugh and ALBI scores miss?
The ALBI grade does not measure physical findings such as ascites or confusion, and it does not assess portal hypertension. Child-Pugh includes some of these clinical features but can be affected by differences in how they are judged. Your care team may recommend additional tests or assessments, including evaluation for portal hypertension or liver transplantation, when appropriate.
What symptoms require emergency care if I have HCC or liver disease?
New or rapidly worsening confusion, vomiting blood, black stools, or severe abdominal pain require immediate emergency medical care. These symptoms can signal a serious complication and should not wait for a routine appointment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my current ALBI grade, and how does it compare to my Child-Pugh score?
  2. 2.How do these liver function scores influence which HCC treatments are considered safe for me?
  3. 3.Are there other factors, like infection, nutrition, or kidney issues, that might be affecting my albumin or bilirubin numbers right now?
  4. 4.Do I need additional assessments for things these scores miss, like portal hypertension or a liver transplant evaluation?
  5. 5.How often will we recheck my albumin and bilirubin levels to monitor my liver function during treatment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma.

    Demirtas CO, D'Alessio A, Rimassa L, et al.

    JHEP reports : innovation in hepatology 2021; (3(5)):100347 doi:10.1016/j.jhepr.2021.100347.

    PMID: 34505035
  2. 2

    Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma and other liver diseases.

    Feng D, Wang M, Hu J, et al.

    Annals of translational medicine 2020; (8(8)):553 doi:10.21037/atm.2020.02.116.

    PMID: 32411776
  3. 3

    Using the Albumin-Bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinoma.

    Mohammadi H, Abuodeh Y, Jin W, et al.

    Journal of gastrointestinal oncology 2018; (9(5)):840-846 doi:10.21037/jgo.2018.05.14.

    PMID: 30505583
  4. 4

    Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma.

    Chan AW, Kumada T, Toyoda H, et al.

    Journal of gastroenterology and hepatology 2016; (31(7)):1300-6 doi:10.1111/jgh.13291.

    PMID: 26751608
  5. 5

    Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma.

    Wang YY, Zhong JH, Su ZY, et al.

    The British journal of surgery 2016; (103(6)):725-734 doi:10.1002/bjs.10095.

    PMID: 27005482
  6. 6

    Predicting Post-Hepatectomy Liver Failure in HCC Patients: A Review of Liver Function Assessment Based on Laboratory Tests Scores.

    Morandi A, Risaliti M, Montori M, et al.

    Medicina (Kaunas, Lithuania) 2023; (59(6)) doi:10.3390/medicina59061099.

    PMID: 37374303
  7. 7

    Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.

    Hiraoka A, Kumada T, Michitaka K, et al.

    Journal of gastroenterology and hepatology 2016; (31(5)):1031-6 doi:10.1111/jgh.13250.

    PMID: 26647219
  8. 8

    Development and validation of prealbumin-bilirubin score (preALBI score) for predicting long-term survival after hepatectomy for hepatocellular carcinoma: A multicenter analysis versus ALBI score.

    Li C, Wang MD, Sun XD, et al.

    American journal of surgery 2024; (232()):87-94 doi:10.1016/j.amjsurg.2024.01.009.

    PMID: 38238192
  9. 9

    Albumin-bilirubin score as a practical tool for prognostication in metabolic-associated steatotic liver disease.

    Lee CW

    World journal of hepatology 2025; (17(12)):113844 doi:10.4254/wjh.v17.i12.113844.

    PMID: 41479515
  10. 10

    Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic.

    Tada T, Kumada T, Toyoda H, et al.

    Journal of gastroenterology and hepatology 2019; (34(6)):1066-1073 doi:10.1111/jgh.14564.

    PMID: 30549320
  11. 11

    Prognostic Value of the Albumin-Bilirubin Grade for the Prediction of Post-Hepatectomy Liver Failure: A Systematic Review and Meta-Analysis.

    Marasco G, Alemanni LV, Colecchia A, et al.

    Journal of clinical medicine 2021; (10(9)) doi:10.3390/jcm10092011.

    PMID: 34066674
  12. 12

    A Comparative Study of Albumin-Bilirubin Score with Child-Pugh Score, Model for End-Stage Liver Disease Score and Indocyanine Green R15 in Predicting Posthepatectomy Liver Failure for Hepatocellular Carcinoma Patients.

    Zou H, Yang X, Li QL, et al.

    Digestive diseases (Basel, Switzerland) 2018; (36(3)):236-243 doi:10.1159/000486590.

    PMID: 29495004
  13. 13

    ALBI versus child-pugh in predicting outcome of patients with HCC: A systematic review.

    Peng Y, Wei Q, He Y, et al.

    Expert review of gastroenterology & hepatology 2020; (14(5)):383-400 doi:10.1080/17474124.2020.1748010.

    PMID: 32240595
  14. 14

    Comparison between Child-Pugh score and Albumin-Bilirubin grade in the prognosis of patients with HCC after liver resection using time-dependent ROC.

    Zhao S, Wang M, Yang Z, et al.

    Annals of translational medicine 2020; (8(8)):539 doi:10.21037/atm.2020.02.85.

    PMID: 32411762

This page is for informational purposes only and does not constitute medical advice. Your hepatologist or oncology team should interpret your Child-Pugh and ALBI results and discuss treatment options for your situation.

Get notified when new evidence is published on Adult hepatocellular carcinoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.